1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease

Margherita Teresa-Anna Cantorna, C. Munsick, C. Bemiss, B. D. Mahon

Research output: Contribution to journalArticle

383 Citations (Scopus)

Abstract

Anecdotal data suggest that the amount of vitamin D available in the environment either from sunshine exposure or diet may be an important factor affecting the development of inflammatory bowel disease (IBD) in humans. We tested the vitamin D hypothesis in an experimental animal model of IBD. Interleukin (IL)-10 knockout (KO) mice, which spontaneously develop symptoms resembling human IBD, were made vitamin D deficient, vitamin D sufficient or supplemented with active vitamin D (1,25-dihydroxycholecalciferol). Vitamin D-deficient IL-10 KO mice rapidly developed diarrhea and a wasting disease, which induced mortality. In contrast, vitamin D-sufficient 1L-10 KO mice did not develop diarrhea, waste or die. Supplementation with 50 IU of cholecalciferol (5.0 μg/d) or 1,25-dihydroxycholecalciferol (0.005 μg/d) significantly (P < 0.05) ameliorated symptoms of IBD in IL-10 KO mice. 1,25-Dihydroxycholecalciferol treatment (0.2 μg/d) for as little as 2 wk blocked the progression and ameliorated (P < 0.05) symptoms in IL-10 KO mice with already established IBD.

Original languageEnglish (US)
Pages (from-to)2648-2652
Number of pages5
JournalJournal of Nutrition
Volume130
Issue number11
StatePublished - 2000

Fingerprint

calcitriol
Calcitriol
inflammatory bowel disease
vitamin D
Inflammatory Bowel Diseases
Vitamin D
signs and symptoms (animals and humans)
Knockout Mice
interleukin-10
mice
Interleukin-10
Diarrhea
diarrhea
Wasting Syndrome
wasting syndrome
cholecalciferol
Cholecalciferol
Sunlight
laboratory animals
solar radiation

All Science Journal Classification (ASJC) codes

  • Medicine (miscellaneous)
  • Food Science

Cite this

@article{7be4615c03a946108cee9d8e7a6f61ea,
title = "1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease",
abstract = "Anecdotal data suggest that the amount of vitamin D available in the environment either from sunshine exposure or diet may be an important factor affecting the development of inflammatory bowel disease (IBD) in humans. We tested the vitamin D hypothesis in an experimental animal model of IBD. Interleukin (IL)-10 knockout (KO) mice, which spontaneously develop symptoms resembling human IBD, were made vitamin D deficient, vitamin D sufficient or supplemented with active vitamin D (1,25-dihydroxycholecalciferol). Vitamin D-deficient IL-10 KO mice rapidly developed diarrhea and a wasting disease, which induced mortality. In contrast, vitamin D-sufficient 1L-10 KO mice did not develop diarrhea, waste or die. Supplementation with 50 IU of cholecalciferol (5.0 μg/d) or 1,25-dihydroxycholecalciferol (0.005 μg/d) significantly (P < 0.05) ameliorated symptoms of IBD in IL-10 KO mice. 1,25-Dihydroxycholecalciferol treatment (0.2 μg/d) for as little as 2 wk blocked the progression and ameliorated (P < 0.05) symptoms in IL-10 KO mice with already established IBD.",
author = "Cantorna, {Margherita Teresa-Anna} and C. Munsick and C. Bemiss and Mahon, {B. D.}",
year = "2000",
language = "English (US)",
volume = "130",
pages = "2648--2652",
journal = "Journal of Nutrition",
issn = "0022-3166",
publisher = "American Society for Nutrition",
number = "11",

}

1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. / Cantorna, Margherita Teresa-Anna; Munsick, C.; Bemiss, C.; Mahon, B. D.

In: Journal of Nutrition, Vol. 130, No. 11, 2000, p. 2648-2652.

Research output: Contribution to journalArticle

TY - JOUR

T1 - 1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease

AU - Cantorna, Margherita Teresa-Anna

AU - Munsick, C.

AU - Bemiss, C.

AU - Mahon, B. D.

PY - 2000

Y1 - 2000

N2 - Anecdotal data suggest that the amount of vitamin D available in the environment either from sunshine exposure or diet may be an important factor affecting the development of inflammatory bowel disease (IBD) in humans. We tested the vitamin D hypothesis in an experimental animal model of IBD. Interleukin (IL)-10 knockout (KO) mice, which spontaneously develop symptoms resembling human IBD, were made vitamin D deficient, vitamin D sufficient or supplemented with active vitamin D (1,25-dihydroxycholecalciferol). Vitamin D-deficient IL-10 KO mice rapidly developed diarrhea and a wasting disease, which induced mortality. In contrast, vitamin D-sufficient 1L-10 KO mice did not develop diarrhea, waste or die. Supplementation with 50 IU of cholecalciferol (5.0 μg/d) or 1,25-dihydroxycholecalciferol (0.005 μg/d) significantly (P < 0.05) ameliorated symptoms of IBD in IL-10 KO mice. 1,25-Dihydroxycholecalciferol treatment (0.2 μg/d) for as little as 2 wk blocked the progression and ameliorated (P < 0.05) symptoms in IL-10 KO mice with already established IBD.

AB - Anecdotal data suggest that the amount of vitamin D available in the environment either from sunshine exposure or diet may be an important factor affecting the development of inflammatory bowel disease (IBD) in humans. We tested the vitamin D hypothesis in an experimental animal model of IBD. Interleukin (IL)-10 knockout (KO) mice, which spontaneously develop symptoms resembling human IBD, were made vitamin D deficient, vitamin D sufficient or supplemented with active vitamin D (1,25-dihydroxycholecalciferol). Vitamin D-deficient IL-10 KO mice rapidly developed diarrhea and a wasting disease, which induced mortality. In contrast, vitamin D-sufficient 1L-10 KO mice did not develop diarrhea, waste or die. Supplementation with 50 IU of cholecalciferol (5.0 μg/d) or 1,25-dihydroxycholecalciferol (0.005 μg/d) significantly (P < 0.05) ameliorated symptoms of IBD in IL-10 KO mice. 1,25-Dihydroxycholecalciferol treatment (0.2 μg/d) for as little as 2 wk blocked the progression and ameliorated (P < 0.05) symptoms in IL-10 KO mice with already established IBD.

UR - http://www.scopus.com/inward/record.url?scp=0033745125&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033745125&partnerID=8YFLogxK

M3 - Article

VL - 130

SP - 2648

EP - 2652

JO - Journal of Nutrition

JF - Journal of Nutrition

SN - 0022-3166

IS - 11

ER -